Building on Bruker’s proprietary Opto-Electrical Positioning (OEP) technology and scalable OptoSelect™ microfluidic chips, Beacon Discovery complements the floor-standing premium Beacon® platforms.
Client programs using CHOMax follow platform-defined workflows and phase-appropriate practices across the development lifecycle.
Successfully producing large quantities of biotherapeutics, including monoclonal antibodies and recombinant protein products, depends on robust and reliable cell line development (CLD). Issues that ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback